4//SEC Filing
McHale Duncan 4
Accession 0001694665-21-000022
CIK 0001694665other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:30 PM ET
Size
9.1 KB
Accession
0001694665-21-000022
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+96,500→ 96,500 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (96,500 underlying)
Footnotes (1)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:30 PM ET
- Size
- 9.1 KB